专利号:US-2005080260-A1 优先权日:2003-04-22 标 题 :Preparation of prodrugs for selective drug delivery 发明人:MILLS RANDELL L; WU GUO-ZHANG 摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.
专利号:US-5262331-A 优先权日:1989-08-28 标 题 :Method for monitoring in peptide synthesis 发明人:SALISBURY STEPHEN; TREMEER JOHN; OWEN DAVID; DAVIES JOHN 权利人:SALISBURY STEPHEN; TREMEER JOHN; OWEN DAVID; DAVIES JOHN 摘要:A method for monitoring the reaction between an activated carboxylic acid derivative and an amine, such as the formation of a peptide bond in peptide synthesis, whereby an inert anionic dye component and an inert cationic component are included in the reaction system, in small relative amounts compared to the carboxylic acid derivative. The distribution of the dye component to the cationic component, when separated from the amine component, is monitored and at a given maximum value indicates a substantially quantitative reaction.
1: Hurst J, Schnichels S, Spitzer MS, Bartz-Schmidt KU, Farecki ML, Szurman P, Januschowski K. Negative Effects of Acid Violet-17 and MBB Dual In Vitro on Different Ocular Cell Lines. Curr Eye Res. 2017 Aug;42(8):1209-1214. doi: 10.1080/02713683.2017.1285942. Epub 2017 Mar 30. doi: 10.1016/j.scijus.2016.05.004. Epub 2016 May 12. doi: 10.1055/s-0041-111823. Epub 2016 Apr 26. Review. doi: 10.1016/j.forsciint.2014.08.027. Epub 2014 Sep 3. Testing the effects of the dye acid violet-17 on retinal function for an intraocular application in vitreo-retinal surgery. Graefes Arch Clin Exp Ophthalmol. 2014 Dec;252(12):1927-37. doi: 10.1007/s00417-014-2761-9. Epub 2014 Sep 14. doi: 10.1016/j.scijus.2013.05.002. Epub 2013 Jun 7. doi: 10.1007/s00417-013-2258-y. Epub 2013 Jan 18. doi: 10.1016/j.jhazmat.2010.12.038. Epub 2010 Dec 15. doi: 10.1016/j.jbiotec.2009.06.011. Epub 2009 Jun 17. doi: 10.1080/01480540902862277. Epub 2007 Jun 2. Japanese.
合成参考文献
参考文献:10.1007/s00417-015-3193-x 摘要:Steel DHW, Karimi AA, White K. An evaluation of two heavier-than-water internal limiting membrane-specific dyes during macular hole surgery. Graefe's Archive for Clinical and Experimental Ophthalmology. 2015 Oct 10;254(7):1289–95. doi: 10.1007/s00417-015-3193-x. 参考文献:10.1007/s12010-008-8234-z 摘要:Chhabra M, Mishra S, Sreekrishnan TR. Mediator-assisted Decolorization and Detoxification of Textile Dyes/Dye Mixture by Cyathus bulleri Laccase. Applied Biochemistry and Biotechnology. 2008 May 28;151(2-3):587–98. doi: 10.1007/s12010-008-8234-z.